| Molecular Formula | C₃₂H₃₉N₇O₄ |
| Molar Mass | 585.70 |
| Storage Condition | -20℃ |
| Use | TAK-788 is the next generation of potent and selective small molecule tyrosine kinase inhibitors (TKIs) designed intelligently and investigated clinically to inhibit epidermal growth factor receptor (EGFR) and human EGFR 2 (HER2) exon 20 mutations, has selectivity for wild-type (WT) EGFR. |
| 1mg | 5mg | 10mg | |
|---|---|---|---|
| 1 mM | 1.707 ml | 8.537 ml | 17.074 ml |
| 5 mM | 0.341 ml | 1.707 ml | 3.415 ml |
| 10 mM | 0.171 ml | 0.854 ml | 1.707 ml |
| 5 mM | 0.034 ml | 0.171 ml | 0.341 ml |